Compounds > scandium
Page last updated: 2024-08-22

scandium and Cancer of Prostate

scandium has been researched along with Cancer of Prostate in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Boros, E; Cingoranelli, SJ; Lapi, SE; Loveless, CS; Schlyer, D; Vaughn, BA1
Archimandritis, SC; Fellner, M; Koumarianou, E; Loktionova, NS; Mikolajczak, R; Pawlak, D; Roesch, F; Thews, O1

Other Studies

2 other study(ies) available for scandium and Cancer of Prostate

ArticleYear
Evaluation of
    Molecular pharmaceutics, 2021, 12-06, Volume: 18, Issue:12

    Topics: Animals; Chelating Agents; Dipeptides; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Male; Mice; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Scandium; Tissue Distribution

2021
44Sc-DOTA-BN[2-14]NH2 in comparison to 68Ga-DOTA-BN[2-14]NH2 in pre-clinical investigation. Is 44Sc a potential radionuclide for PET?
    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2012, Volume: 70, Issue:12

    Topics: Animals; Bombesin; Cell Line, Tumor; Gallium Radioisotopes; Gastrin-Releasing Peptide; Heterocyclic Compounds, 1-Ring; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Rats; Scandium; Tissue Distribution

2012